Acadia Pharmaceuticals (ACAD) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -80.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.53% |
| Dec 31, 2025 | 90.30% |
| Sep 30, 2025 | 119.11% |
| Jun 30, 2025 | -20.19% |
| Mar 31, 2025 | 14.78% |
| Dec 31, 2024 | 214.15% |
| Sep 30, 2024 | 150.30% |
| Jun 30, 2024 | 2,822.13% |
| Mar 31, 2024 | 138.48% |
| Dec 31, 2023 | 209.80% |
| Sep 30, 2023 | -139.74% |
| Jun 30, 2023 | 103.36% |
| Mar 31, 2023 | 61.95% |
| Dec 31, 2022 | 3.29% |
| Sep 30, 2022 | -87.92% |
| Jun 30, 2022 | 22.57% |
| Mar 31, 2022 | -70.14% |
| Dec 31, 2021 | 35.24% |
| Sep 30, 2021 | 82.92% |
| Jun 30, 2021 | -4.11% |
| Mar 31, 2021 | 24.51% |
| Dec 31, 2020 | -25.48% |
| Sep 30, 2020 | -101.68% |
| Jun 30, 2020 | 23.30% |
| Mar 31, 2020 | -3.19% |
| Dec 31, 2019 | 19.07% |
| Sep 30, 2019 | 32.44% |
| Jun 30, 2019 | 13.16% |
| Mar 31, 2019 | -57.11% |
| Dec 31, 2018 | 4.82% |
| Sep 30, 2018 | 4.77% |
| Jun 30, 2018 | 6.19% |
| Mar 31, 2018 | 38.19% |
| Dec 31, 2017 | 10.99% |
| Sep 30, 2017 | 8.89% |
| Jun 30, 2017 | 5.44% |
| Mar 31, 2017 | -76.53% |
| Dec 31, 2016 | -222.09% |
| Sep 30, 2016 | -84.07% |
| Jun 30, 2016 | -81.12% |
| Mar 31, 2016 | -23.25% |
| Dec 31, 2015 | 89.57% |
| Sep 30, 2015 | -56.97% |
| Jun 30, 2015 | -83.20% |
| Mar 31, 2015 | -126.47% |
| Dec 31, 2014 | 150.43% |
| Sep 30, 2014 | -131.75% |
| Jun 30, 2014 | -136.70% |
| Mar 31, 2014 | -191.16% |
| Dec 31, 2013 | 295.98% |
| Sep 30, 2013 | -345.25% |
| Jun 30, 2013 | -67.58% |
| Mar 31, 2013 | 1.53% |
| Dec 31, 2012 | -28.49% |
| Sep 30, 2012 | 52.68% |
| Jun 30, 2012 | 17.34% |
| Mar 31, 2012 | -6.60% |
| Dec 31, 2011 | -118.19% |
| Sep 30, 2011 | -20.09% |